Novartis’ Indian Patent Challenge Could Harm: MSF

Law360, New York (September 26, 2006, 12:00 AM EDT) -- International aid organization Medecins Sans Frontieres lashed out at Novartis AG on Tuesday, saying the Swiss drug maker’s challenge to a key section of India’s recently enacted patent laws could seriously impact future access to essential medicines in other nations.

"If Novartis' challenge against the Indian patent law is successful, a key safeguard that can protect the production of affordable medicines will be lost," said Ellen 't Hoen, policy director at MSF's Campaign for Access to Essential Medicines. "People the world over who rely on India...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.